Page last updated: 2024-08-24

thiazolyl blue and 6-hydroxytaxol

thiazolyl blue has been researched along with 6-hydroxytaxol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ando, Y; Bates, SE; Blagosklonny, MV; Figg, WD; Fojo, T; Kang, MH; Liewehr, D	1

Trials

1 trial(s) available for thiazolyl blue and 6-hydroxytaxol

Article	Year
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:6 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bilirubin; Chromatography, High Pressure Liquid; Coloring Agents; Cyclosporins; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Microsomes, Liver; Models, Chemical; Paclitaxel; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors	2001

Article

Year

The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:6

Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bilirubin; Chromatography, High Pressure Liquid; Coloring Agents; Cyclosporins; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Microsomes, Liver; Models, Chemical; Paclitaxel; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors

2001